Tentative Approval
06-08-2010 |
20:45 hs.
APP Pharmaceuticals Inc. said that the Food and Drug Administration cleared marketing of Sanofi-Aventis SA generic version of Eloxatin, indicated to treat colon cancer.
Will cost a third of the original drug
04-08-2010 |
18:00 hs.
Cipla Ltd. announced presentation in India of a generic version of German Bayer AF and U.S. Onyx Biopharmaceuticlas Inc., indicated to treat advanced liver and renal cancer.
04-08-2010 |
17:50 hs.
The Food and Drug Administration cleared Mylan Inc. to market generic laxative version of Braintree Laboratories Inc. drug, NuLytely.
06-01-2009 |
13:14 hs.
Mylan Inc.announced tentative Food and Drug Administration approval for generic version of principal asthma and allergy Merck & Co drug, Singulair (Montelukast). The drug patent is under review by the U.S. Patent and Trademark Office (PTO). Details.
12-15-2008 |
17:45 hs.
MDRNA Inc. said that the U.S. Food and Drug Administration has granted a tentative approval of its Abbreviated new drug application or ANDA for generic calcitonin-salmon nasal spray for the treatment of osteoporosis.
11-17-2008 |
17:48 hs.
10-30-2008 |
11:40 hs.
09-17-2008 |
11:34 hs.
09-08-2008 |
10:21 hs.
08-25-2008 |
12:27 hs.
08-21-2008 |
11:32 hs.
07-03-2008 |
15:00 hs.
Top-seller patents expire in 2012
06-13-2008 |
10:41 hs.
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Teva Pharmaceutical Industries Ltd´s generic form of Novartis AG´s blockbuster high blood pressure drug Diovan, Teva announced.
Lupin´s version of Topamax
05-30-2008 |
10:58 hs.
04-17-2008 |
12:27 hs.
Glaucoma Drug
04-11-2008 |
11:25 hs.
04-03-2008 |
09:03 hs.
Generic Ovarian Cancer Drug
03-06-2008 |
11:38 hs.
02-14-2008 |
13:24 hs.
